Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell CarcinomaEduard Roussel, Maarten Albersen, Matthias Heck et al.|European Urology Oncology|2020Cited by 50
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)Michele Marchioni, Maria Carmen Mir, Maximilian C. Kriegmair et al.|European Urology Oncology|2020Cited by 34
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 (“Oligometastatic”) and M2 (“Polymetastatic”) subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)Margaret Meagher, Ithaar Derweesh, Maria Carmen Mir et al.|Frontiers in Oncology|2023Cited by 8
Minimally invasive versus open cytoreductive nephrectomy for primary metastatic renal cancer: A multi-institutional experience from the REMARCC registryRiccardo Campi, Maria Carmen Mir, Michele Marchioni et al.|European Urology Open Science|2020Cited by 1
Proposal for a two-tier re-classification of stage IV/M1 renal cell carcinoma into M1 (oligometastatic) and M2 (polymetastatic) sub stagesMargaret Meagher, Ithaar Derweesh, Mujahid Ahmad Mir et al.|European Urology Open Science|2020Cited by 0